Matinas BioPharma Holdings, Inc. Quarterly report pursuant to sections 13 or 15(d)

FORMATION AND REVERSE ACQUISITION OF MATINAS BIOPHARMA HOLDINGS - Merger (Details Textual) (Merger [Member], USD $)	1 Months Ended
	Jul. 31, 2013
Formation And Reverse Acquisition [Line Items]
Stock Issued During Period, Shares, New Issues	9,000,000
Aggregate Common Stock Holding Percentage	28.50%
Warrants Isuued For Purchase Of Common Stock	1,000,000
Warrants Exercise Price	$ 2.00
Herbert Conrad [Member]
Formation And Reverse Acquisition [Line Items]
Stock Issued During Period, Shares, New Issues	351,563
Warrants Isuued For Purchase Of Common Stock	250,000
Roelof Rongen [Member]
Formation And Reverse Acquisition [Line Items]
Stock Issued During Period, Shares, New Issues	3,417,186
Abdel A Fawzy [Member]
Formation And Reverse Acquisition [Line Items]
Stock Issued During Period, Shares, New Issues	1,708,593
George Bobotas And His Spouse [Member]
Formation And Reverse Acquisition [Line Items]
Stock Issued During Period, Shares, New Issues	1,366,875
Jerome Jabbour [Member]
Formation And Reverse Acquisition [Line Items]
Stock Issued During Period, Shares, New Issues	759,374
Stefano Ferrari [Member]
Formation And Reverse Acquisition [Line Items]
Stock Issued During Period, Shares, New Issues	351,563
Warrants Isuued For Purchase Of Common Stock	250,000